112 related articles for article (PubMed ID: 33768570)
1. Atractylenolide III predisposes miR-195-5p/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer.
Sheng L; Li J; Li N; Gong L; Liu L; Zhang Q; Li X; Luo H; Chen Z
J Food Biochem; 2021 May; 45(5):e13582. PubMed ID: 33768570
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
[TBL] [Abstract][Full Text] [Related]
3. miR-664b-5p Inhibits Hepatocellular Cancer Cell Proliferation Through Targeting Oncogene AKT2.
Li H; Guo D; Zhang Y; Yang S; Zhang R
Cancer Biother Radiopharm; 2020 Oct; 35(8):605-614. PubMed ID: 31967930
[No Abstract] [Full Text] [Related]
4. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
5. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
Xu J; Wang Y; Zhang Y; Dang S; He S
Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line.
Zhao G; Han C; Zhang Z; Wang L; Xu J
Biochem Biophys Res Commun; 2017 Aug; 490(2):371-377. PubMed ID: 28623129
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
10. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma.
Wei XC; Xia YR; Zhou P; Xue X; Ding S; Liu LJ; Zhu F
World J Gastroenterol; 2021 Dec; 27(48):8302-8322. PubMed ID: 35068871
[TBL] [Abstract][Full Text] [Related]
11. miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA.
Cui W; Li Y; Xu K; Chen G; Lu X; Duan Q; Kang Z
Biochem Biophys Res Commun; 2016 Oct; 479(4):901-906. PubMed ID: 27641667
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
13. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
Wang JT; Wang ZH
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
Shen Q; Cicinnati VR; Zhang X; Iacob S; Weber F; Sotiropoulos GC; Radtke A; Lu M; Paul A; Gerken G; Beckebaum S
Mol Cancer; 2010 Aug; 9():227. PubMed ID: 20799954
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
18. MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1.
Li P; Xiao Z; Luo J; Zhang Y; Lin L
J Cell Mol Med; 2019 Apr; 23(4):2475-2488. PubMed ID: 30710422
[TBL] [Abstract][Full Text] [Related]
19. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.
Zhao JA; Nie W; Dong L; Liu W; Wei W
J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329
[TBL] [Abstract][Full Text] [Related]
20. Atractylenolide III Enhances the Anti-Neoplastic Efficacy of Docetaxel in Gastric Cancer Cell by Inhibiting Fibroblast Growth Factor Receptors 1, -2, and -4 Expression.
Ji Y; Kang Z; Kang N; Zhao Y; Guo Q; Chen Y
J Environ Pathol Toxicol Oncol; 2019; 38(3):217-227. PubMed ID: 31679309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
